Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

When was vyvanse created?

See the DrugPatentWatch profile for vyvanse

Vyvanse (lisdexamfetamine dimesylate) was first described as a chemical compound in the early 1960s, but it didn’t enter the pharmaceutical market until much later.

Milestone Year What happened
First synthesis 1961 The pro‑drug structure of lisdexamfetamine was first reported in a French chemistry paper.
Early research 1960s–1990s The compound was studied in laboratory settings but not pursued for therapeutic use.
Commercial development Early 2000s Shire (later acquired by Takeda) began developing lisdexamfetamine as a pro‑drug of dextroamphetamine for attention‑deficit/hyperactivity disorder (ADHD).
FDA approval 2007 The U.S. Food and Drug Administration approved Vyvanse for the treatment of ADHD in children, adolescents, and adults, and later for binge‑eating disorder.

So, while the chemical existed as far back as the 1960s, the product that we know as Vyvanse was created by pharmaceutical developers in the early 2000s and approved by the FDA in 2007.



Other Questions About Vyvanse :

vyvanse patent expiration How much does vyvanse cost in canada? Vyvanse 40 mg cost? Vyvanse 70 mg price? Vyvanse ingredients list? Street price vyvanse? Cost vyvanse?